News & Updates

Accrued physical activity may have positive effects on weight, adiposity in overweight adults

10 Jan 2024

Some adults who are either obese or overweight tend to see themselves as less physically active than they actually are, suggests a study. However, accumulating at least 150 min/wk of moderate-to-vigorous physical activity (MVPA) can already provide benefits on a person’s weight and adiposity status.

Accrued physical activity may have positive effects on weight, adiposity in overweight adults

10 Jan 2024

Aspirin reduces liver fat, improves markers of inflammation, fibrosis

04 Jan 2024 by

Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) – previously called nonalcoholic fatty liver disease (NAFLD) – but without cirrhosis, who were treated with daily low-dose aspirin, had significant reductions in liver fat for 6 months in a new trial.

Aspirin reduces liver fat, improves markers of inflammation, fibrosis

04 Jan 2024

Shifting to a plant-based diet may be key to better cardiometabolic health

27 Dec 2023 by

A systematic review and meta-analysis of prospective studies demonstrate that switching from animal-based (AB) to plant-based (PB) foods conferred cardiometabolic improvements.

Shifting to a plant-based diet may be key to better cardiometabolic health

27 Dec 2023

Faecal matter transplant exerts no beneficial effect on cardiometabolic risk factors

23 Dec 2023

Faecal microbiota transplantation (FMT) does not appear to have any significant effect on the cardiometabolic parameters of individuals with at least one cardiometabolic issue, according to the results of a systematic review and meta-analysis.

Faecal matter transplant exerts no beneficial effect on cardiometabolic risk factors

23 Dec 2023

Metformin plus insulin for T2D, gestational diabetes does little to improve neonatal outcomes

23 Dec 2023

Treatment with metformin plus insulin early in pregnancy for women with pre-existing type 2 diabetes (T2D) or gestational diabetes falls short of reducing the risk of adverse neonatal outcomes, as shown in the MOMPOD study.

Metformin plus insulin for T2D, gestational diabetes does little to improve neonatal outcomes

23 Dec 2023

Somapacitan safe, effective in children with growth hormone deficiency

21 Dec 2023 by

Use of somapacitan, a long-acting growth hormone (GH) derivative, for 2 years is efficacious and well tolerated in prepubertal children with GH deficiency (GHD), reports a study.

Somapacitan safe, effective in children with growth hormone deficiency

21 Dec 2023

Serum DHEA, testosterone levels inversely linked to CAC in older men

21 Dec 2023

In older men, serum levels of dehydroepiandrosterone (DHEA) and testosterone correlate inversely with coronary artery calcification (CAC), partially independently from each other, a study has shown.

Serum DHEA, testosterone levels inversely linked to CAC in older men

21 Dec 2023

Even seemingly healthy teens with high BMI at risk of early CKD

18 Dec 2023

High body mass index (BMI) in late adolescence appears to be a risk factor for chronic kidney disease (CKD) in young adulthood, even for seemingly healthy individuals with a BMI that falls within the normal range but is closer to the upper limit, as reported in a study.

Even seemingly healthy teens with high BMI at risk of early CKD

18 Dec 2023

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

18 Dec 2023 by

Etelcalcetide proves beneficial in the real-world treatment of secondary hyperparathyroidism (SHPT) in multiethnic Asian haemodialysis patients, with the added advantage of reducing pill burden, as shown in a study from Singapore.

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

18 Dec 2023

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D

17 Dec 2023

Early albuminuria reduction with finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is responsible for a huge proportion of the treatment effect against CKD progression and facilitates a modest amount of the effect against cardiovascular outcomes, reports a study.

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D

17 Dec 2023

News & Updates

Filter by Specialty:

Specialty:

Accrued physical activity may have positive effects on weight, adiposity in overweight adults

Accrued physical activity may have positive effects on weight, adiposity in overweight adults

Aspirin reduces liver fat, improves markers of inflammation, fibrosis

Aspirin reduces liver fat, improves markers of inflammation, fibrosis

Shifting to a plant-based diet may be key to better cardiometabolic health

Shifting to a plant-based diet may be key to better cardiometabolic health

Faecal matter transplant exerts no beneficial effect on cardiometabolic risk factors

Faecal matter transplant exerts no beneficial effect on cardiometabolic risk factors

Metformin plus insulin for T2D, gestational diabetes does little to improve neonatal outcomes

Metformin plus insulin for T2D, gestational diabetes does little to improve neonatal outcomes

Somapacitan safe, effective in children with growth hormone deficiency

Somapacitan safe, effective in children with growth hormone deficiency

Serum DHEA, testosterone levels inversely linked to CAC in older men

Serum DHEA, testosterone levels inversely linked to CAC in older men

Even seemingly healthy teens with high BMI at risk of early CKD

Even seemingly healthy teens with high BMI at risk of early CKD

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

Real-world data favour etelcalcetide for treating SHPT in multiethnic Asians

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D